Australia
Our TGA-licensed depot in South Australia has supported over 1,000 clinical trials since its inception, currently managing more than 350. Equipped with sophisticated temperature-controlled infrastructure, the facility offers global depot and advanced healthcare logistics such as cold chain and a smart sourcing solution for access to medicines.
Opportunities
  • Clinical Trial Supplies Market to reach USD 5.7B by 2027.
  • Healthcare CROs market in Australia and New Zealand valued at USD 1B in 2022.
  • CAGR of 11.5% expected for healthcare CROs market from 2023-2030.
  • Virtual clinical trials adoption to drive CRO industry growth in the region.
  • Clinical trials in Australia offer R&D tax advantages and cost efficiency, driving industry growth.
Capabilities
  • Global depot & cold chain logistics for reliable healthcare delivery.
  • Sophisticated temperature-controlled. infrastructure adhering to industry standards (GDP, GMP, CSV, HSE).
  • Smart Sourcing Solution for unparalleled access to medicine, incl. controlled drugs.
  • Specialised cold chain for temperature-sensitive materials.
  • Innovative patient-centric approach to clinical trials with depot-to-patient solutions.